Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.68 USD | -2.03% | -20.01% | +149.48% |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Apr. 10 | Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.15B |
---|---|---|---|---|---|
Net income 2024 * | -118M | Net income 2025 * | -130M | EV / Sales 2024 * | - |
Net Debt 2024 * | 293M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18.3
x | P/E ratio 2025 * |
-16.8
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
Latest transcript on Vera Therapeutics, Inc.
1 day | -1.32% | ||
1 week | -19.13% | ||
Current month | -8.44% | ||
1 month | -4.80% | ||
3 months | +164.79% | ||
6 months | +285.17% | ||
Current year | +156.70% |
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 38.59 | -2.25% | 232 556 |
24-04-18 | 39.48 | -1.32% | 856,999 |
24-04-17 | 40.01 | -6.01% | 1,069,915 |
24-04-16 | 42.57 | -8.51% | 1,315,673 |
24-04-15 | 46.53 | -3.00% | 1,344,030 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+156.70% | 2.15B | |
-1.82% | 41.35B | |
+41.70% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- VERA Stock